Start Your NewsReadery Pro FREE TRIAL!

Register and verify your email address to start your NewsReadery Pro FREE TRIAL today!

Login / Register

sciencedaily.com / .sciencedaily-com-health / Page 4

Top Health News -- ScienceDaily
Quick Menu features require JavaScript!
Popular News
 
A new treatment that blocks an aging-related protein restored lost cartilage in old mice and helped prevent arthritis after knee injuries. Human cartilage samples showed similar signs of regeneration, raising hopes for a future drug that could repair ...
A potentially dangerous tapeworm linked to severe, cancer-like disease has now been found in the Pacific Northwest, marking its first detection in wild animals along the U.S. West Coast. Researchers discovered the parasite, Echinococcus ...
Researchers gave top AI models a classic attention test used in psychology and found a major flaw. While the models could correctly name colors in short lists, their performance deteriorated sharply as the task became longer and more complex. Some .. ...
A groundbreaking new connectome maps every neural connection in an adult fruit fly's central nervous system, creating an unprecedented view of how the brain and body work together. The findings suggest that complex behaviors emerge from distributed . ...
A major study suggests glucosamine, a popular supplement for joint pain, could be linked to faster progression from mild cognitive impairment to Alzheimer's disease. Researchers found a 25% higher likelihood of developing dementia among glucosamine . ...
A common sign of hearing loss isn't complete silence -- it's struggling to follow conversations, especially in noisy places. Experts say hearing loss and tinnitus, the ringing or buzzing many people experience, often start when delicate cells inside ...
"Chemo brain" affects up to 80% of people receiving chemotherapy, making everyday tasks harder. In a new trial, cancer patients who followed a home-based exercise program showed better attention and fewer noticeable cognitive problems than those who ...
Continue
Please wait ...